Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort

BACKGROUND: There are limited data on the outcomes of rechallenge with anti-tuberculosis therapy (ATT) following anti-tuberculosis drug-induced liver injury (AT-DILI) in a high HIV prevalence setting. OBJECTIVES: To describe the outcomes of rechallenge with first-line ATT. METHOD: Hospitalised parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosa, Muhammed Shiraz, Maartens, Gary, Gunter, Hannah, Allie, Shaazia, Chughlay, Mohamed F., Setshedi, Mashiko, Wasserman, Sean, Stead, David F., Cohen, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257779/
https://www.ncbi.nlm.nih.gov/pubmed/35923608
http://dx.doi.org/10.4102/sajhivmed.v23i1.1376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257779/
https://www.ncbi.nlm.nih.gov/pubmed/35923608
http://dx.doi.org/10.4102/sajhivmed.v23i1.1376

Ejemplares similares